Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physiologic pharmacokinetic modeling.

W A Colburn1

  • 1Pharmacokinetics/Drug Metabolism Department, Parke-Davis Pharmaceutical Research, Warner-Lambert Company, Ann Arbor, Michigan 48105.

Journal of Clinical Pharmacology
|August 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thalidomide dose proportionality assessment following single doses to healthy subjects.

Journal of clinical pharmacology·2001
Same author

Pharmacokinetic/pharmacodynamic modeling in drug research and development.

Journal of clinical pharmacology·2001
Same author

Optimizing the use of biomarkers, surrogate endpoints, and clinical endpoints for more efficient drug development.

Journal of clinical pharmacology·2001
Same author

Hemoglobin and methemoglobin concentrations after large-dose infusions of diaspirin cross-linked hemoglobin.

Anesthesia and analgesia·2001
Same author

Effect of a high-fat meal on thalidomide pharmacokinetics and the relative bioavailability of oral formulations in healthy men and women.

Biopharmaceutics & drug disposition·2000
Same author

An evolution of drug development and clinical pharmacology during the 20th century.

Journal of clinical pharmacology·2000
Same journal

AI is Excellent at the Discovery and Identification of Unrecognized Scientific Knowledge but There Is No Evidence That AI Can Create New Scientific Knowledge.

Journal of clinical pharmacology·2026
Same journal

Ketamine Dosing Across Clinical Indications: A Narrative Review Organized by Proposed NMDA-Related Mechanisms.

Journal of clinical pharmacology·2026
Same journal

Flip-Flop Pharmacokinetics in Pregnancy and the Future of Obstetric Pharmacology.

Journal of clinical pharmacology·2026
Same journal

Correction to "A Phase 1 Study Evaluating the Pharmacokinetics and Safety of Avacopan in Participants With End-Stage Kidney Disease on Hemodialysis".

Journal of clinical pharmacology·2026
Same journal

Street Pharmacology: The Mechanistic Basis of Clinical Pharmacology Underlying the Microdosing Method of Buprenorphine-Naloxone With a Focus on the Unhoused Population.

Journal of clinical pharmacology·2026
Same journal

Ontology-Enhanced Deep Learning for Mechanistic Prediction of Drug-Drug Interactions: A Clinically Interpretable Framework.

Journal of clinical pharmacology·2026
See all related articles

Physiologic modeling may form the foundation for future pharmacokinetic/pharmacodynamic (PK/PD) approaches. Further development in vitro and animal-to-human predictions could elevate its role in pharmacokinetic modeling.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Physiologic Modeling

Background:

  • Physiologic modeling, despite initial high expectations, has not achieved widespread adoption in pharmaceutical research.
  • Current applications are limited, suggesting a need for further development and validation.

Purpose of the Study:

  • To explore the potential of physiologic modeling as a foundational element for future pharmacokinetic/pharmacodynamic (PK/PD) modeling.
  • To identify pathways for enhancing the utility and acceptance of physiologic modeling in drug development.

Main Methods:

  • Review of current trends and limitations in physiologic modeling.
  • Analysis of the potential for integrating in vitro and animal-to-human extrapolation techniques.
  • Discussion of the hierarchical positioning of modeling approaches in pharmacokinetics.

Related Experiment Videos

Main Results:

  • Physiologic modeling shows promise as a basis for advanced PK/PD modeling.
  • Improved in vitro and animal-to-human prediction methods are crucial for advancing physiologic modeling.
  • The integration of these advancements could significantly elevate the status of physiologic modeling.

Conclusions:

  • Physiologic modeling, while currently underutilized, holds significant potential for future pharmacokinetic research.
  • Continued research and development, particularly in predictive accuracy from in vitro and animal studies, are essential.
  • This approach may become a more prominent tool in the pharmacokinetic modeling hierarchy.